UBS analyst Manav Gupta maintains Calumet Specialty Prods (NASDAQ:CLMT) with a Neutral and raises the price target from $18.5 to $19.5.
UBS Maintains Neutral on Calumet Specialty Prods, Raises Price Target to $19.5
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.